Elizabeth Bertone-Johnson
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Premenstrual Syndrome | 28 | 2025 | 99 | 9.160 |
Why?
|
| Menopause | 22 | 2024 | 260 | 6.210 |
Why?
|
| Diet | 22 | 2024 | 533 | 3.850 |
Why?
|
| Menopause, Premature | 9 | 2023 | 26 | 3.770 |
Why?
|
| Vitamin D | 16 | 2022 | 139 | 3.760 |
Why?
|
| Anti-Mullerian Hormone | 12 | 2024 | 66 | 3.670 |
Why?
|
| Prospective Studies | 62 | 2025 | 3315 | 3.260 |
Why?
|
| Postmenopause | 17 | 2022 | 238 | 2.630 |
Why?
|
| Risk Factors | 67 | 2025 | 5339 | 2.600 |
Why?
|
| Female | 146 | 2025 | 33351 | 2.540 |
Why?
|
| Adult | 99 | 2025 | 17117 | 2.360 |
Why?
|
| Depression | 14 | 2024 | 909 | 2.020 |
Why?
|
| Premenopause | 11 | 2024 | 61 | 2.000 |
Why?
|
| Breast Feeding | 3 | 2024 | 153 | 1.840 |
Why?
|
| Humans | 153 | 2025 | 64243 | 1.830 |
Why?
|
| Body Mass Index | 22 | 2024 | 872 | 1.780 |
Why?
|
| Hot Flashes | 3 | 2024 | 101 | 1.720 |
Why?
|
| Young Adult | 42 | 2025 | 4776 | 1.680 |
Why?
|
| Dietary Proteins | 3 | 2019 | 44 | 1.680 |
Why?
|
| Menarche | 3 | 2024 | 37 | 1.650 |
Why?
|
| Case-Control Studies | 24 | 2024 | 1130 | 1.620 |
Why?
|
| Nurses | 11 | 2024 | 109 | 1.570 |
Why?
|
| Self Report | 10 | 2024 | 388 | 1.570 |
Why?
|
| Exercise | 8 | 2018 | 954 | 1.500 |
Why?
|
| Sterilization, Tubal | 2 | 2021 | 11 | 1.420 |
Why?
|
| Menstrual Cycle | 9 | 2025 | 82 | 1.390 |
Why?
|
| Middle Aged | 61 | 2025 | 17899 | 1.370 |
Why?
|
| Dietary Fats | 5 | 2023 | 175 | 1.340 |
Why?
|
| Surveys and Questionnaires | 29 | 2024 | 2737 | 1.320 |
Why?
|
| Parity | 3 | 2021 | 71 | 1.320 |
Why?
|
| Inflammation | 9 | 2023 | 1162 | 1.300 |
Why?
|
| Sexual and Gender Minorities | 4 | 2024 | 78 | 1.290 |
Why?
|
| Calcium, Dietary | 4 | 2017 | 29 | 1.280 |
Why?
|
| Adolescent | 35 | 2025 | 6304 | 1.250 |
Why?
|
| Breast | 4 | 2022 | 190 | 1.250 |
Why?
|
| Feeding Behavior | 5 | 2024 | 264 | 1.220 |
Why?
|
| Breast Neoplasms | 12 | 2022 | 1211 | 1.220 |
Why?
|
| Stress, Psychological | 8 | 2024 | 479 | 1.220 |
Why?
|
| Age Factors | 12 | 2025 | 1569 | 1.180 |
Why?
|
| Cholecalciferol | 4 | 2022 | 28 | 1.130 |
Why?
|
| Cross-Sectional Studies | 28 | 2025 | 2616 | 1.130 |
Why?
|
| Proportional Hazards Models | 13 | 2024 | 735 | 1.110 |
Why?
|
| Bone Density | 4 | 2013 | 137 | 1.100 |
Why?
|
| Women's Health | 6 | 2022 | 374 | 1.090 |
Why?
|
| Health Surveys | 4 | 2024 | 314 | 1.090 |
Why?
|
| Nutritional Status | 2 | 2018 | 99 | 1.080 |
Why?
|
| Cohort Studies | 19 | 2024 | 2604 | 1.080 |
Why?
|
| Cardiovascular Diseases | 5 | 2025 | 848 | 1.070 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2018 | 85 | 1.060 |
Why?
|
| Premature Birth | 6 | 2025 | 115 | 1.050 |
Why?
|
| Premenstrual Dysphoric Disorder | 3 | 2025 | 8 | 1.010 |
Why?
|
| Odds Ratio | 13 | 2023 | 759 | 0.990 |
Why?
|
| Emotions | 4 | 2021 | 227 | 0.980 |
Why?
|
| Calcium | 4 | 2017 | 580 | 0.960 |
Why?
|
| Fatty Acids | 3 | 2023 | 202 | 0.900 |
Why?
|
| Inflammation Mediators | 2 | 2019 | 178 | 0.890 |
Why?
|
| Heterosexuality | 1 | 2024 | 10 | 0.890 |
Why?
|
| Interleukin-10 | 3 | 2023 | 161 | 0.890 |
Why?
|
| Adiposity | 3 | 2022 | 83 | 0.880 |
Why?
|
| Contraceptives, Oral | 2 | 2021 | 23 | 0.880 |
Why?
|
| Alcohol Drinking | 3 | 2021 | 316 | 0.870 |
Why?
|
| C-Reactive Protein | 8 | 2023 | 166 | 0.870 |
Why?
|
| Cigarette Smoking | 3 | 2021 | 57 | 0.860 |
Why?
|
| Vitamins | 5 | 2022 | 79 | 0.850 |
Why?
|
| Dietary Supplements | 9 | 2022 | 239 | 0.850 |
Why?
|
| Pregnancy | 20 | 2025 | 2370 | 0.850 |
Why?
|
| Dairy Products | 4 | 2019 | 16 | 0.840 |
Why?
|
| Logistic Models | 13 | 2023 | 1270 | 0.830 |
Why?
|
| Suicide | 3 | 2016 | 134 | 0.800 |
Why?
|
| Diabetes, Gestational | 3 | 2022 | 142 | 0.790 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 3 | 2019 | 30 | 0.760 |
Why?
|
| Rural Population | 3 | 2016 | 212 | 0.740 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2022 | 158 | 0.740 |
Why?
|
| Prevalence | 8 | 2024 | 1407 | 0.720 |
Why?
|
| Diethylstilbestrol | 1 | 2022 | 51 | 0.720 |
Why?
|
| Alcoholic Beverages | 1 | 2021 | 7 | 0.720 |
Why?
|
| Chronic Pain | 1 | 2024 | 156 | 0.710 |
Why?
|
| Pre-Eclampsia | 1 | 2022 | 69 | 0.710 |
Why?
|
| Mental Health | 4 | 2023 | 372 | 0.700 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1272 | 0.690 |
Why?
|
| Diet, Mediterranean | 1 | 2021 | 17 | 0.680 |
Why?
|
| Environmental Exposure | 5 | 2022 | 220 | 0.670 |
Why?
|
| Incidence | 11 | 2020 | 1383 | 0.650 |
Why?
|
| Eating | 2 | 2019 | 139 | 0.650 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 2478 | 0.650 |
Why?
|
| HIV Infections | 7 | 2023 | 976 | 0.630 |
Why?
|
| Suicidal Ideation | 2 | 2022 | 120 | 0.620 |
Why?
|
| Recreation | 3 | 2017 | 21 | 0.610 |
Why?
|
| Pregnancy Outcome | 5 | 2025 | 195 | 0.610 |
Why?
|
| United States | 20 | 2024 | 7923 | 0.610 |
Why?
|
| Smoking | 7 | 2019 | 861 | 0.610 |
Why?
|
| Endometriosis | 4 | 2024 | 28 | 0.610 |
Why?
|
| Follicle Stimulating Hormone, Human | 1 | 2019 | 4 | 0.600 |
Why?
|
| Smoking Cessation | 4 | 2023 | 551 | 0.600 |
Why?
|
| Thinness | 2 | 2017 | 44 | 0.600 |
Why?
|
| Zinc | 3 | 2016 | 93 | 0.600 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 72 | 0.590 |
Why?
|
| Dietary Fiber | 2 | 2018 | 77 | 0.590 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 104 | 0.590 |
Why?
|
| Coffee | 2 | 2016 | 18 | 0.580 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2018 | 8 | 0.580 |
Why?
|
| Ovarian Neoplasms | 4 | 2006 | 155 | 0.580 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 930 | 0.570 |
Why?
|
| Caffeine | 2 | 2016 | 46 | 0.570 |
Why?
|
| Dogs | 2 | 2012 | 332 | 0.570 |
Why?
|
| Dietary Carbohydrates | 2 | 2018 | 61 | 0.570 |
Why?
|
| Triglycerides | 1 | 2019 | 244 | 0.530 |
Why?
|
| Adult Survivors of Child Abuse | 2 | 2018 | 13 | 0.530 |
Why?
|
| Antidepressive Agents | 4 | 2022 | 226 | 0.520 |
Why?
|
| Lymphoma | 2 | 2012 | 103 | 0.520 |
Why?
|
| Biomarkers | 10 | 2023 | 1431 | 0.510 |
Why?
|
| Coffea | 1 | 2016 | 2 | 0.500 |
Why?
|
| Risk Assessment | 7 | 2025 | 2046 | 0.500 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2007 | 57 | 0.490 |
Why?
|
| Atherosclerosis | 1 | 2018 | 156 | 0.490 |
Why?
|
| Child | 8 | 2024 | 4583 | 0.490 |
Why?
|
| Hypertension | 3 | 2016 | 593 | 0.480 |
Why?
|
| Body Composition | 2 | 2021 | 153 | 0.480 |
Why?
|
| Massachusetts | 15 | 2025 | 2094 | 0.480 |
Why?
|
| Finland | 4 | 2022 | 20 | 0.470 |
Why?
|
| Seasons | 1 | 2016 | 138 | 0.460 |
Why?
|
| Aged | 18 | 2024 | 14648 | 0.450 |
Why?
|
| Infertility, Female | 3 | 2024 | 46 | 0.450 |
Why?
|
| Refugees | 3 | 2021 | 70 | 0.450 |
Why?
|
| Vitamin B Complex | 2 | 2014 | 15 | 0.450 |
Why?
|
| Estrogens | 4 | 2010 | 116 | 0.450 |
Why?
|
| Linear Models | 8 | 2024 | 407 | 0.440 |
Why?
|
| Androgens | 4 | 2023 | 48 | 0.440 |
Why?
|
| Osteoporosis | 2 | 2013 | 108 | 0.430 |
Why?
|
| Domestic Violence | 1 | 2014 | 39 | 0.430 |
Why?
|
| Crime Victims | 1 | 2014 | 35 | 0.420 |
Why?
|
| Estradiol | 5 | 2022 | 258 | 0.420 |
Why?
|
| Abortion, Spontaneous | 2 | 2025 | 31 | 0.420 |
Why?
|
| Sex Offenses | 1 | 2014 | 46 | 0.420 |
Why?
|
| Blood Pressure | 1 | 2016 | 517 | 0.410 |
Why?
|
| Folic Acid | 1 | 2014 | 42 | 0.410 |
Why?
|
| Fatty Acids, Essential | 1 | 2013 | 8 | 0.410 |
Why?
|
| Diet Surveys | 5 | 2019 | 44 | 0.400 |
Why?
|
| Hypersensitivity | 1 | 2014 | 65 | 0.400 |
Why?
|
| Overweight | 2 | 2017 | 252 | 0.400 |
Why?
|
| Insecticides | 2 | 2012 | 45 | 0.400 |
Why?
|
| Iron, Dietary | 1 | 2013 | 9 | 0.400 |
Why?
|
| Minerals | 1 | 2013 | 20 | 0.390 |
Why?
|
| Osteoporotic Fractures | 1 | 2013 | 36 | 0.390 |
Why?
|
| Cat Diseases | 2 | 2003 | 17 | 0.390 |
Why?
|
| Potassium | 1 | 2013 | 100 | 0.380 |
Why?
|
| Sweden | 7 | 2025 | 59 | 0.380 |
Why?
|
| Risk | 6 | 2017 | 379 | 0.370 |
Why?
|
| Dysmenorrhea | 1 | 2012 | 8 | 0.370 |
Why?
|
| Sleep | 2 | 2025 | 231 | 0.370 |
Why?
|
| Prostaglandins | 1 | 2012 | 18 | 0.370 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2009 | 32 | 0.370 |
Why?
|
| Bone Development | 1 | 2012 | 32 | 0.360 |
Why?
|
| Indians, North American | 1 | 2012 | 29 | 0.360 |
Why?
|
| Obesity | 6 | 2022 | 1247 | 0.350 |
Why?
|
| Time Factors | 6 | 2025 | 3724 | 0.340 |
Why?
|
| Absorptiometry, Photon | 2 | 2010 | 76 | 0.340 |
Why?
|
| Mammography | 2 | 2010 | 290 | 0.340 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2023 | 28 | 0.340 |
Why?
|
| Dog Diseases | 1 | 2012 | 60 | 0.340 |
Why?
|
| Vitamin D Deficiency | 3 | 2022 | 42 | 0.340 |
Why?
|
| Anovulation | 2 | 2025 | 10 | 0.340 |
Why?
|
| Social Support | 3 | 2024 | 376 | 0.330 |
Why?
|
| Air Pollutants | 2 | 2022 | 94 | 0.330 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2009 | 17 | 0.330 |
Why?
|
| Calcifediol | 1 | 2010 | 3 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 706 | 0.320 |
Why?
|
| Animals, Domestic | 2 | 2007 | 15 | 0.320 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 197 | 0.310 |
Why?
|
| Attitude to Health | 1 | 2012 | 294 | 0.310 |
Why?
|
| Interleukin-6 | 4 | 2019 | 324 | 0.310 |
Why?
|
| Anxiety | 3 | 2023 | 430 | 0.300 |
Why?
|
| Asthma | 1 | 2014 | 471 | 0.300 |
Why?
|
| Life Style | 3 | 2019 | 317 | 0.280 |
Why?
|
| Male | 21 | 2025 | 30295 | 0.280 |
Why?
|
| Cotinine | 1 | 2007 | 19 | 0.270 |
Why?
|
| Micronutrients | 2 | 2018 | 21 | 0.270 |
Why?
|
| Cause of Death | 2 | 2024 | 222 | 0.260 |
Why?
|
| Health Behavior | 1 | 2010 | 474 | 0.260 |
Why?
|
| Child Abuse | 2 | 2022 | 89 | 0.260 |
Why?
|
| Health Status | 1 | 2009 | 447 | 0.260 |
Why?
|
| Child Abuse, Sexual | 2 | 2018 | 25 | 0.240 |
Why?
|
| Legislation, Drug | 1 | 2025 | 18 | 0.240 |
Why?
|
| Dihydroxycholecalciferols | 1 | 2005 | 2 | 0.230 |
Why?
|
| Flax | 3 | 2011 | 7 | 0.230 |
Why?
|
| Hydrocortisone | 2 | 2024 | 193 | 0.230 |
Why?
|
| Antioxidants | 1 | 2007 | 256 | 0.230 |
Why?
|
| Alaska | 3 | 2016 | 5 | 0.230 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 270 | 0.230 |
Why?
|
| Unemployment | 1 | 2025 | 18 | 0.230 |
Why?
|
| Marijuana Smoking | 1 | 2025 | 19 | 0.230 |
Why?
|
| Sick Leave | 1 | 2025 | 23 | 0.230 |
Why?
|
| Marijuana Use | 1 | 2025 | 22 | 0.230 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 383 | 0.230 |
Why?
|
| Bisexuality | 1 | 2024 | 15 | 0.220 |
Why?
|
| Sweating | 1 | 2024 | 27 | 0.220 |
Why?
|
| Cannabis | 1 | 2025 | 52 | 0.220 |
Why?
|
| Homosexuality, Female | 1 | 2024 | 22 | 0.220 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2238 | 0.210 |
Why?
|
| Bhutan | 5 | 2022 | 20 | 0.210 |
Why?
|
| Schools | 1 | 2025 | 170 | 0.210 |
Why?
|
| Ultraviolet Rays | 2 | 2022 | 141 | 0.210 |
Why?
|
| Receptors, Calcitriol | 3 | 2009 | 34 | 0.210 |
Why?
|
| India | 2 | 2024 | 158 | 0.210 |
Why?
|
| Psychological Tests | 1 | 2024 | 46 | 0.210 |
Why?
|
| Nails | 1 | 2024 | 39 | 0.200 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2019 | 390 | 0.200 |
Why?
|
| Students | 1 | 2025 | 222 | 0.200 |
Why?
|
| Selenium | 1 | 2023 | 25 | 0.200 |
Why?
|
| Breast Diseases | 2 | 2021 | 45 | 0.200 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 34 | 0.200 |
Why?
|
| Live Birth | 1 | 2022 | 21 | 0.190 |
Why?
|
| Contraceptive Agents | 1 | 2022 | 12 | 0.190 |
Why?
|
| Child, Preschool | 3 | 2024 | 2018 | 0.190 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2023 | 17 | 0.190 |
Why?
|
| Pediatric Obesity | 1 | 2024 | 113 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 172 | 0.180 |
Why?
|
| Body Height | 1 | 2022 | 66 | 0.180 |
Why?
|
| Mass Screening | 1 | 2007 | 693 | 0.180 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 40 | 0.180 |
Why?
|
| Birth Weight | 1 | 2022 | 85 | 0.180 |
Why?
|
| Follicular Atresia | 1 | 2021 | 3 | 0.180 |
Why?
|
| Infant, Small for Gestational Age | 4 | 2017 | 29 | 0.180 |
Why?
|
| Confidence Intervals | 4 | 2012 | 239 | 0.170 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 387 | 0.170 |
Why?
|
| Depressive Disorder | 2 | 2014 | 286 | 0.170 |
Why?
|
| Weight Gain | 1 | 2022 | 168 | 0.170 |
Why?
|
| Quality of Life | 2 | 2025 | 1257 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2003 | 259 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 171 | 0.170 |
Why?
|
| Racism | 1 | 2022 | 88 | 0.170 |
Why?
|
| Contraception | 1 | 2021 | 71 | 0.170 |
Why?
|
| Puberty | 1 | 2021 | 59 | 0.170 |
Why?
|
| Air Pollution | 1 | 2020 | 36 | 0.160 |
Why?
|
| Cytokines | 2 | 2015 | 944 | 0.160 |
Why?
|
| Severity of Illness Index | 3 | 2012 | 1561 | 0.160 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 94 | 0.160 |
Why?
|
| Mental Disorders | 2 | 2022 | 794 | 0.160 |
Why?
|
| Work Schedule Tolerance | 1 | 2019 | 22 | 0.150 |
Why?
|
| Prognosis | 2 | 2015 | 1769 | 0.150 |
Why?
|
| Dyslipidemias | 1 | 2019 | 37 | 0.150 |
Why?
|
| Suicide, Attempted | 3 | 2022 | 107 | 0.150 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2018 | 4 | 0.150 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 18 | 0.140 |
Why?
|
| Resilience, Psychological | 1 | 2019 | 61 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 869 | 0.140 |
Why?
|
| Puerto Rico | 6 | 2017 | 138 | 0.140 |
Why?
|
| Sexual Behavior | 1 | 2020 | 195 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2011 | 85 | 0.140 |
Why?
|
| Body Weight | 2 | 2017 | 379 | 0.140 |
Why?
|
| Epidemiologic Studies | 1 | 2018 | 34 | 0.140 |
Why?
|
| Carotid Intima-Media Thickness | 1 | 2018 | 13 | 0.140 |
Why?
|
| Abdominal Fat | 1 | 2017 | 6 | 0.140 |
Why?
|
| Stearic Acids | 1 | 2017 | 10 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1102 | 0.130 |
Why?
|
| Infant, Newborn | 6 | 2021 | 1375 | 0.130 |
Why?
|
| Age of Onset | 1 | 2018 | 175 | 0.130 |
Why?
|
| Sex Distribution | 2 | 2016 | 251 | 0.130 |
Why?
|
| ROC Curve | 1 | 2018 | 288 | 0.130 |
Why?
|
| Age Distribution | 2 | 2016 | 258 | 0.130 |
Why?
|
| Interleukin-4 | 2 | 2015 | 146 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2017 | 46 | 0.130 |
Why?
|
| Interleukin-12 | 2 | 2015 | 127 | 0.130 |
Why?
|
| Interleukin-2 | 2 | 2015 | 167 | 0.130 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 402 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2019 | 192 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 37 | 0.120 |
Why?
|
| Tea | 1 | 2016 | 32 | 0.120 |
Why?
|
| Double-Blind Method | 2 | 2022 | 744 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2017 | 209 | 0.120 |
Why?
|
| Nepal | 3 | 2023 | 96 | 0.120 |
Why?
|
| Insulin | 2 | 2017 | 684 | 0.120 |
Why?
|
| Interferon-gamma | 2 | 2015 | 576 | 0.120 |
Why?
|
| Progesterone | 2 | 2014 | 163 | 0.110 |
Why?
|
| Interviews as Topic | 2 | 2020 | 539 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2017 | 486 | 0.110 |
Why?
|
| Trauma Severity Indices | 1 | 2014 | 34 | 0.110 |
Why?
|
| Ovulation Detection | 1 | 2014 | 4 | 0.110 |
Why?
|
| Socioeconomic Factors | 3 | 2012 | 788 | 0.110 |
Why?
|
| Nurse Midwives | 1 | 2014 | 11 | 0.110 |
Why?
|
| Ovulation | 1 | 2014 | 28 | 0.110 |
Why?
|
| Comorbidity | 2 | 2025 | 1118 | 0.110 |
Why?
|
| Parathyroid Hormone | 1 | 2014 | 44 | 0.100 |
Why?
|
| Luteinizing Hormone | 1 | 2014 | 100 | 0.100 |
Why?
|
| Midwifery | 1 | 2014 | 32 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2017 | 409 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2012 | 607 | 0.100 |
Why?
|
| Reproductive Health | 1 | 2014 | 25 | 0.100 |
Why?
|
| Urban Population | 1 | 2015 | 198 | 0.100 |
Why?
|
| Maternal Exposure | 1 | 2014 | 42 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 30 | 0.100 |
Why?
|
| Chemokines | 1 | 2014 | 93 | 0.100 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2011 | 11 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2023 | 1019 | 0.100 |
Why?
|
| Fertility | 2 | 2024 | 83 | 0.100 |
Why?
|
| Health Promotion | 3 | 2022 | 505 | 0.100 |
Why?
|
| Cats | 2 | 2003 | 89 | 0.100 |
Why?
|
| Mastodynia | 1 | 2012 | 3 | 0.090 |
Why?
|
| Mexico | 1 | 2012 | 39 | 0.090 |
Why?
|
| Irritable Mood | 1 | 2012 | 16 | 0.090 |
Why?
|
| Animals | 5 | 2012 | 20962 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 788 | 0.090 |
Why?
|
| Community Mental Health Centers | 1 | 2012 | 18 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 99 | 0.090 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 81 | 0.090 |
Why?
|
| Back Pain | 1 | 2012 | 51 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2012 | 101 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 299 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 53 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 1392 | 0.090 |
Why?
|
| Nutrition Assessment | 2 | 2010 | 28 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 65 | 0.090 |
Why?
|
| Particulate Matter | 2 | 2022 | 65 | 0.090 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 144 | 0.090 |
Why?
|
| C-Peptide | 1 | 2011 | 23 | 0.080 |
Why?
|
| Riboflavin | 1 | 2011 | 17 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2011 | 64 | 0.080 |
Why?
|
| Thiamine | 1 | 2011 | 21 | 0.080 |
Why?
|
| Polymorphism, Genetic | 2 | 2009 | 191 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 467 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2014 | 856 | 0.080 |
Why?
|
| Registries | 2 | 2025 | 885 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2023 | 575 | 0.080 |
Why?
|
| Quality of Health Care | 1 | 2014 | 526 | 0.080 |
Why?
|
| Seasonal Affective Disorder | 1 | 2009 | 2 | 0.080 |
Why?
|
| Biogenic Monoamines | 1 | 2009 | 5 | 0.080 |
Why?
|
| Glucose Intolerance | 1 | 2010 | 90 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 194 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2012 | 756 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 498 | 0.080 |
Why?
|
| Sunlight | 1 | 2009 | 30 | 0.070 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2017 | 36 | 0.070 |
Why?
|
| Algorithms | 1 | 2014 | 1028 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2025 | 6726 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2010 | 309 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2010 | 296 | 0.070 |
Why?
|
| Energy Intake | 2 | 2024 | 171 | 0.070 |
Why?
|
| Sex Factors | 2 | 2023 | 979 | 0.060 |
Why?
|
| Heart Failure | 1 | 2015 | 926 | 0.060 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2006 | 48 | 0.060 |
Why?
|
| Colonic Polyps | 1 | 2006 | 24 | 0.060 |
Why?
|
| Prolactin | 1 | 2006 | 40 | 0.060 |
Why?
|
| Lactose | 1 | 2006 | 10 | 0.060 |
Why?
|
| Infant, Low Birth Weight | 2 | 2017 | 60 | 0.060 |
Why?
|
| Diet Records | 1 | 2005 | 34 | 0.060 |
Why?
|
| Siblings | 1 | 2025 | 43 | 0.060 |
Why?
|
| Perception | 1 | 2006 | 178 | 0.060 |
Why?
|
| Europe | 1 | 2005 | 197 | 0.050 |
Why?
|
| New Hampshire | 1 | 2024 | 44 | 0.050 |
Why?
|
| Meals | 1 | 2024 | 23 | 0.050 |
Why?
|
| Pregnancy Trimester, First | 2 | 2017 | 25 | 0.050 |
Why?
|
| Fast Foods | 1 | 2024 | 13 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1669 | 0.050 |
Why?
|
| Hazardous Substances | 1 | 2003 | 15 | 0.050 |
Why?
|
| Food Handling | 1 | 2024 | 58 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2024 | 153 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 276 | 0.050 |
Why?
|
| Testosterone | 1 | 2023 | 121 | 0.050 |
Why?
|
| Benzene | 1 | 2022 | 7 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2022 | 31 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 3 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 727 | 0.050 |
Why?
|
| Estrone | 1 | 2022 | 13 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2022 | 123 | 0.050 |
Why?
|
| Reproductive History | 1 | 2022 | 17 | 0.050 |
Why?
|
| Ovarian Reserve | 1 | 2021 | 9 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2012 | 5691 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 771 | 0.040 |
Why?
|
| Pain | 1 | 2024 | 407 | 0.040 |
Why?
|
| Brain | 1 | 2009 | 1581 | 0.040 |
Why?
|
| Glucose Tolerance Test | 2 | 2010 | 97 | 0.040 |
Why?
|
| Parents | 1 | 2024 | 395 | 0.040 |
Why?
|
| Problem Solving | 1 | 2020 | 32 | 0.040 |
Why?
|
| Poverty | 2 | 2015 | 299 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2018 | 10 | 0.040 |
Why?
|
| Psychological Trauma | 1 | 2018 | 21 | 0.040 |
Why?
|
| Dominican Republic | 1 | 2017 | 25 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2017 | 19 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2022 | 483 | 0.030 |
Why?
|
| Educational Status | 2 | 2008 | 278 | 0.030 |
Why?
|
| Prenatal Diagnosis | 1 | 2017 | 40 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 728 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1681 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 184 | 0.030 |
Why?
|
| Aging | 1 | 2021 | 754 | 0.030 |
Why?
|
| Mice | 1 | 2009 | 11003 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 84 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 39 | 0.030 |
Why?
|
| Interleukin-7 | 1 | 2015 | 29 | 0.030 |
Why?
|
| Yogurt | 1 | 2015 | 5 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Pakistan | 1 | 2015 | 17 | 0.030 |
Why?
|
| Seafood | 1 | 2015 | 14 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 72 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 92 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 133 | 0.030 |
Why?
|
| Vegetables | 1 | 2015 | 69 | 0.030 |
Why?
|
| Urinalysis | 1 | 2014 | 38 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 110 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 75 | 0.030 |
Why?
|
| New York | 1 | 2014 | 143 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 271 | 0.030 |
Why?
|
| Research | 1 | 2014 | 196 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 384 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 616 | 0.020 |
Why?
|
| Leisure Activities | 1 | 2011 | 26 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 368 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2011 | 53 | 0.020 |
Why?
|
| Hydroxyestrones | 1 | 2010 | 4 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2011 | 174 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 293 | 0.020 |
Why?
|
| Censuses | 1 | 2008 | 17 | 0.020 |
Why?
|
| Maternal Age | 1 | 2008 | 33 | 0.020 |
Why?
|
| Marital Status | 1 | 2008 | 45 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 487 | 0.020 |
Why?
|
| Mortality | 1 | 2008 | 161 | 0.020 |
Why?
|
| Employment | 1 | 2008 | 128 | 0.020 |
Why?
|
| Demography | 1 | 2006 | 174 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 214 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 668 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 512 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 5520 | 0.010 |
Why?
|